MASLD Is Associated With Decreased General Health Perception, Quality of Life and Work Productivity in a Low Fibrosis Population
Abstract
Background: Data on quality of life in a low fibrosis prevalence metabolic dysfunction-associated steatotic liver disease (MASLD) cohort are scarce, as previous research has focused on advanced fibrosis and cirrhosis. This study examined the association between steatosis and general and mental health, as well as productivity in patients in primary care and a diabetes population.
Methods: Three cohort studies were conducted in Belgian and Dutch primary care and a Belgian hospital. Liver stiffness (> 12 kPa) and steatosis (> 275 dB/m) were measured using vibration-controlled transient elastography and controlled attenuation parameter (CAP). Participants completed questionnaires measuring anxiety (GAD-7), depression (PHQ-9), work productivity (WPAI-SHP), and general health (SF-36), and data were analysed with Spearman correlation.
Results: Of 311 participants, 142 (45.7%) and 15 (4.7%) had steatosis and fibrosis. Individuals with steatosis had a higher BMI (30.5 kg/m2 vs. 25.5 kg/m2, p < 0.001), increased liver stiffness (5.7 kPa vs. 4.6 kPa, p < 0.001), lower general health scores (SF-36, p < 0.001) and physical functioning (SF-36, p = 0.024) compared to those without. No significant differences were found for depression (p = 0.955) or anxiety (p = 0.557). Absenteeism was more prevalent in the steatosis group (p = 0.016), though the reasons for absenteeism were mostly unrelated to steatosis. Higher CAP values were negatively correlated with physical functioning (r = -0.193, p…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 311 participants or records.
Read the paper
Related studies
- A Coupled SYSTEM of Intracellular Ca 2+ Clocks and Surface Membrane Voltage Clocks Controls the Timekeeping Mechanism of the Heart’s Pacemaker
- A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin
- Cancer epigenetics: Moving forward
- Current developments in LC-MS for pharmaceutical analysis
- Myricetin: A comprehensive review on its biological potentials
- A Computational Systems Biology Software Platform for Multiscale Modeling and Simulation: Integrating Whole-Body Physiology, Disease Biology, and Molecular Reaction Networks
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.